Last reviewed · How we verify
NCT03401606
Controlled Sedation for Cataract Surgery
Phase 4 trial testing remifentanil in Failed Conscious Sedation During Procedure in 98 participants. Terminated before completion.
30 October 2015
Quick facts
| Lead sponsor | Fundación Universitaria de Ciencias de la Salud |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 98 |
| Start date | 1 November 2014 |
| Primary completion | 30 October 2015 |
| Estimated completion | 30 January 2016 |
Drugs / interventions tested
- remifentanil — full drug profile →
- Dexmedetomidine (dexmedetomidine) — full drug profile →
Conditions studied
- Failed Conscious Sedation During Procedure — all drugs for Failed Conscious Sedation During Procedure →
Sponsor
Fundación Universitaria de Ciencias de la Salud — full company profile →
Who can join
18 and older, any sex, with Failed Conscious Sedation During Procedure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the surgeon and patient´s satisfaction who undergoes cataract surgery using either dexmedetomidine or remifentanil as sedation
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03401606
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of remifentanil
Trials testing the same drug.
- NCT05686863 — Remiazolam Combined With Esketamine in Painless Bidirectional Endoscopy in Children · NA · completed
- NCT04364945 — Association Between Anesthetic Drugs for General Anesthesia and Postoperative Intelligence/behavioral Assessment Results · NA · active not recruiting
- NCT04372342 — The Effect of Analgesic Drugs on Respiratory Center · Phase 4 · unknown
- NCT04387097 — Drip-infusion of Remifentanil for RIH · completed
- NCT03152981 — Analysis of Change of Optic Nerve Sheath Diameter in Robot Assisted Laparoscopic Radical Prostatectomy · NA · completed
Other Fundación Universitaria de Ciencias de la Salud trials
Trials by the same sponsor.
- NCT04539873 — Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 · Phase 3 · terminated
- NCT04768413 — Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis · unknown
- NCT04860544 — Is Red Blood Cell Transfusion a Risk Factor for Vascular Pedicle Thrombosis? The Study Case of a Latin American Cohort · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03401606 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Universitaria de Ciencias de la Salud
- Last refreshed: 17 January 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03401606.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing